|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.735 EUR | +8.10% |
|
+0.58% | -56.62% |
Sequana Medical NV reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 0.923 million compared to EUR 0.371 million a year ago. Net loss was EUR 30.76 million compared to EUR 23.62 million a year ago.
Basic loss per share from continuing operations was EUR 1.35 compared to EUR 1.3 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -56.62% | 5.27Cr | |
| +54.05% | 6.39TCr | |
| -2.02% | 4.18TCr | |
| +40.01% | 4.05TCr | |
| -10.22% | 2.72TCr | |
| +13.42% | 2.65TCr | |
| -21.60% | 1.87TCr | |
| +2.89% | 1.27TCr | |
| +22.40% | 1.21TCr | |
| +27.49% | 1.21TCr |
SEQUANA MEDICAL N.V. 
